China's biopharmaceutical firm Akeso jumps most in 10 weeks on strong annual sales

Akeso

16/03/2023 04:27

** Shares of China's biopharmaceutical firm Akeso Inc
 9926.HK  jump as much as 9% to HK$46.75, their biggest daily
pct rise since Jan 3, if gains hold
    * Stock touches the highest since Feb 10, on track for
fourth consecutive session of gain; fifth biggest pct gainer in
the Hang Seng Composite Index  .HSCI  
    ** Guangdong-based biological products developer says total
products sales for 2022 increased by 422% to 1.1 bln yuan
($159.30 mln), comprehensive loss narrowed to 1.29 bln yuan from
1.31 bln yuan loss in the previous year
    ** The Hang Seng Commerce & Industry Index  .HSNC  falls
1.3% and the healthcare index  .HSCIH  slips 0.9%
    ** The Hang Seng Composite Index  .HSCI  declines 1.3% and
the Hang Seng Index  .HSI  drops 1.5%
    
 ($1 = 6.9050 Chinese yuan)

 (Reporting by Donny Kwok)
 ((donny.kwok@thomsonreuters.com))